Aubrai

Live

Longevity

Aubrai is the world’s first decentralized scientific agent with knowledge stemming from thousands of private lab notes, internal chats and unpublished insights from the lab of Dr. Aubrey de Grey and the collective intelligence of the global longevity community. Co-developed by VitaDAO and BIO, the first BioAgent is designed to fight the greatest killer of all time: Aging. As an onchain AI co-scientist, Aubrai can generate and validate hypotheses, design wet-lab experiments and encrypt data when asked, enriching research outputs while protecting trade secrets. At the heart of Aubrai's mission lies the Robust Mouse Rejuvenation (RMR2) project – Aubrey's ambitious study to double the remaining lifespan of middle‑aged mice. If successful, it could be aging's "AlphaFold moment": a proof that multi‑target rejuvenation works and is worth scaling.

$AUBRAI

BASE

Community Sentiment

How do you feel about Aubrai?

...

No trend data

Market Details

BASE

Staking Available

Updates

Feed

View @aubrai_ on X

Project

Aubrey de Grey

President and Chief Scientific Officer | LEVF

Caitlin Lewis

Director of Project Pipeline & Strategy | LEVF

David Wood

Executive Director | LEVF

Alex Dobrin

Guardian and Web3 Co-lead | VitaDAO

Alex Miloski

Web3 Co-Lead and Longevity Interim Lead | VitaDAO

Johannes Weniger

AI Developer | VitaDAO

Rhys Anderson

Scientific Evaluator | VitaDAO

Matt McAllister

Scientific Evaluator | VitaDAO

Aakaash Meduri

Head of AI | BIO

Aubrey de Grey

President and Chief Scientific Officer | LEVF

Caitlin Lewis

Director of Project Pipeline & Strategy | LEVF

David Wood

Executive Director | LEVF

Alex Dobrin

Guardian and Web3 Co-lead | VitaDAO

Alex Miloski

Web3 Co-Lead and Longevity Interim Lead | VitaDAO

Johannes Weniger

AI Developer | VitaDAO

Rhys Anderson

Scientific Evaluator | VitaDAO

Matt McAllister

Scientific Evaluator | VitaDAO

Aakaash Meduri

Head of AI | BIO

Q3 2025

RMR2 PILOT STUDY FUNDED

BIO and VitaDAO co-funded Aubrey's RMR2 pilot studies, aiming to validate candidate interventions and optimize administration modalities

CHAT UI CLOSED BETA

Invite-only access for community scientists to test Aubrai's capabilities as co-scientist

AUBRAI EOA WALLET

POI MINTING

One-click onchain minting of Proof-of-Idea (PoI) NFTs for research ideas

DEEP RESEARCH

Stronger retrieval, reasoning, and experiment design

CHAT UI PUBLIC ACCESS

Open access to Aubrai’s co-scientist chat for all users

Q4 2025

SEMI-AUTONOMOUS AGENT

Full Base AgentKit integration enabling unrestricted transaction execution and full financial autonomy

FAILURE DB PUBLICLY AVAILABLE

Open database of non-confirmatory results and design flaws to avoid repetition of mistakes

FULLY AUTONOMOUS RESEARCH

End-to-end scientific output: from hypothesis generation to study design, wet lab execution and publication

Market Overview

Summary

Aubrai turns decades of longevity expertise into a 24/7 research co-pilot — delivering source-linked, real-time insights to accelerate aging science for scientists, founders, and funders. It runs inside a confidential Phala Cloud TEE on ElizaOS v2, combining a 10k-pair synthetic Q&A finetune with a living biomedical literature knowledge graph to minimize hallucinations and maximize actionable clarity.

Problem

Aging research generates a vast and fast-changing body of literature, making it difficult for researchers and innovators to access concise, validated, and context-aware answers. Traditional search and manual curation slow discovery and hinder collaborative problem-solving.

Impact

By distilling cutting-edge evidence and integrating it with domain expertise, AubrAI helps users accelerate hypothesis generation, intervention design, and experimental decision-making. This translates into faster discovery cycles, better-informed interventions, and more effective allocation of research resources.